Pacira Pharmaceuticals, Inc. Reports 2013 Financial Results: Fourth Quarter EXPAREL Revenues Increase 53 Percent Over Third Quarter

[Business Wire] – Pacira Pharmaceuticals, Inc. today provided updates on the commercial success of EXPAREL® for postsurgical pain in the Un more

View todays social media effects on PCRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Pacira is hiring next, click here to view